PROCAINAMIDE DISPOSITION IN OBESITY

被引：34
作者：
CHRISTOFF, PB
CONTI, DR
NAYLOR, C
JUSKO, WJ
机构：
[1] SUNY BUFFALO,SCH PHARM,DIV CLIN PHARM SCI,BUFFALO,NY 14260
[2] SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,BUFFALO,NY 14260
[3] MILLARD FILLMORE HOSP,BUFFALO,NY 14209
来源：
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1983年 / 17卷 / 7-8期
关键词：
D O I：
10.1177/106002808301700704
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：516 / 522
页数：7
相关论文
共 36 条
[11]   ESTIMATING CREATININE CLEARANCE IN MORBIDLY OBESE PATIENTS [J].
DIONNE, RE ;
BAUER, LA ;
GIBSON, GA ;
GRIFFEN, WO ;
BLOUIN, RA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (06) :841-844
[12]   ANTIARRHYTHMIC POTENCY OF N-ACETYLPROCAINAMIDE [J].
ELSON, J ;
STRONG, JM ;
LEE, WK ;
ATKINSON, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (02) :134-140
[13]   DIGOXIN METABOLISM IN OBESITY [J].
EWY, GA ;
GROVES, BM ;
BALL, MF ;
NIMMO, L ;
JACKSON, B ;
MARCUS, F .
CIRCULATION, 1971, 44 (05) :810-+
[14]  
GAL P, 1978, CLIN PHARMACOL THER, V23, P438
[15]  
GALEAZZI RL, 1975, CLIN PHARMACOL THER, V19, P55
[16]   A QUANTITATIVE APPROACH TO BIOCHEMICAL STRUCTURE-ACTIVITY RELATIONSHIPS [J].
HANSCH, C .
ACCOUNTS OF CHEMICAL RESEARCH, 1969, 2 (08) :232-&
[17]  
Jusko WJ, 1980, APPLIED PHARMACOKINE, P639
[18]   CORONARY HEART-DISEASE - OVERWEIGHT AND OBESITY AS RISK FACTORS [J].
KEYS, A ;
KARVONEN, MJ ;
MENOTTI, A ;
VANBUCHE.FS ;
TAYLOR, HL ;
PUDDU, V ;
BUZINA, R ;
BLACKBURN, H ;
ARAVANIS, C ;
DJORDJEVIC, BS ;
FIDANZA, F .
ANNALS OF INTERNAL MEDICINE, 1972, 77 (01) :15-+
[19]   PROCAINAMIDE DOSAGE SCHEDULES, PLASMA CONCENTRATIONS, AND CLINICAL EFFECTS [J].
KOCHWESER, J ;
KLEIN, SW .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 215 (09) :1454-+
[20]   THE EFFECT OF OBESITY ON ACETAMINOPHEN PHARMACOKINETICS IN MAN [J].
LEE, WH ;
KRAMER, WG ;
GRANVILLE, GE .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (07) :284-287
1234